Search
for
Sort by
Research 481–510 of 1000+
- New drug targets and research methods for androgenetic alopecia
- Vesicular Carriers for Follicular Drug Delivery
- Ethosome as a potential transdermal drug delivery system
- Epidermal Growth Factor Receptor Inhibitor–Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema: Should You Discontinue the Offending Agent?
- Transethosomes: A Breakthrough System for Transdermal and Topical Drug Delivery
- A Novel Effect of Acyclovir on Hair Growth in BALB/c Mice: A Promising Future for Finding a New Topical Drug for the Treatment of Hirsutism
- Influences of skin barrier, a nanoparticle-based vehicle and solvents on cutaneous drug delivery
- Cutaneous drug reactions
- Transdermal Drug Delivery of Finasteride Ethosomes and Finasteride Liposomes
- Workplace Drug Testing Using Hair Samples
- Percutaneous drug delivery to the hair follicle
- Nurses' Drug Alert
- Finasteride prescribed for hair loss consistently leads to depression. Comment on ‘Depression risk of 5-alpha reductase inhibitors: impact of active-comparator versus non-drug user control groups on risk measurement’
- Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance
- Advances in the Treatment of Androgenetic Alopecia: A Review of Mechanisms and the Clinical Efficacy of Combination Drug Therapy
- Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions—A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data
- Unlocking Hair Follicles as Drug Reservoirs: Advances in Transfollicular Drug Delivery
- The forensic limits of hair drug testing: a critical assessment of drug intake and hair concentration relationships
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization
- Theoretical investigation on the construction of hair follicle membranes and the transdermal drug delivery mechanisms of JAK inhibitors via distinct pathways
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- "A Critical Review: Recent Advances in Ethosomal Gel for Transdermal Drug Delivery Systems''
- Development of a 3D In Vitro Model of Dupuytren’s Disease as a Platform for Drug Screening
- Coexistence of alopecia areata and fixed drug eruption: An uncommon isotopic phenomenon?
- Multi-targeted synergy of Bacillus sp. TC5 fermentation products for transdermal drug delivery and hair regeneration
- Niosomal Nanoformulations for Targeted Follicular Drug Delivery in Alopecia: An Integrative Review of Pathophysiology, Therapies, and Nanotechnology-Based Approaches
- Novel Drug Delivery Systems and Emerging Molecular Targets in Androgenetic Alopecia: A Comprehensive Review of Next-Generation Therapeutics
- Microneedle-Based Technologies for Long-Acting Transdermal Drug Delivery in Wearable Devices
- Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health